Page last updated: 2024-10-22

amantadine and Deafness, Sudden

amantadine has been researched along with Deafness, Sudden in 1 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Deafness, Sudden: Complete sensorineural hearing loss which develops suddenly over a period of hours or a few days.

Research Excerpts

ExcerptRelevanceReference
" This is the first report on the occurrence of sudden hearing loss in six cases of chronic hepatitis C in temporal relation to treatment with pegylated (PEG)-IFN alfa2a or b/ribavirin combination therapy."9.11Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. ( Denk, DM; Ferenci, P; Formann, E; Gangl, A; Jessner, W; Munda-Steindl, P; Stauber, R; Zollner, G, 2004)
" This is the first report on the occurrence of sudden hearing loss in six cases of chronic hepatitis C in temporal relation to treatment with pegylated (PEG)-IFN alfa2a or b/ribavirin combination therapy."5.11Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. ( Denk, DM; Ferenci, P; Formann, E; Gangl, A; Jessner, W; Munda-Steindl, P; Stauber, R; Zollner, G, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Formann, E1
Stauber, R1
Denk, DM1
Jessner, W1
Zollner, G1
Munda-Steindl, P1
Gangl, A1
Ferenci, P1

Trials

1 trial available for amantadine and Deafness, Sudden

ArticleYear
Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:5

    Topics: Adult; Amantadine; Audiometry; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug

2004